467 related articles for article (PubMed ID: 32899140)
1. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis.
Tsukazaki H; Kaito T
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899140
[TBL] [Abstract][Full Text] [Related]
2. Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.
McGonagle D; Watad A; Sharif K; Bridgewood C
Front Immunol; 2021; 12():614255. PubMed ID: 33815371
[TBL] [Abstract][Full Text] [Related]
3. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
[TBL] [Abstract][Full Text] [Related]
4. ILC3 in Axial Spondyloarthritis: the Gut Angle.
Mauro D; Macaluso F; Fasano S; Alessandro R; Ciccia F
Curr Rheumatol Rep; 2019 Jun; 21(7):37. PubMed ID: 31197599
[TBL] [Abstract][Full Text] [Related]
5. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.
Reinhardt A; Prinz I
Front Immunol; 2018; 9():885. PubMed ID: 29922283
[TBL] [Abstract][Full Text] [Related]
6. IL-17 in the immunopathogenesis of spondyloarthritis.
Taams LS; Steel KJA; Srenathan U; Burns LA; Kirkham BW
Nat Rev Rheumatol; 2018 Aug; 14(8):453-466. PubMed ID: 30006601
[TBL] [Abstract][Full Text] [Related]
7. Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.
Ceribelli A; Motta F; Vecellio M; Isailovic N; Ciccia F; Selmi C
Front Immunol; 2021; 12():622770. PubMed ID: 34149686
[TBL] [Abstract][Full Text] [Related]
8. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study.
Zarco P; González CM; Rodríguez de la Serna A; Peiró E; Mateo I; Linares L; Calvo J; Cea-Calvo L; Arteaga MJ; Vanaclocha F; Marín-Jiménez I; García-Vicuña R
Reumatol Clin; 2015; 11(2):83-9. PubMed ID: 25441489
[TBL] [Abstract][Full Text] [Related]
9. The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis.
Yeremenko N; Paramarta JE; Baeten D
Curr Opin Rheumatol; 2014 Jul; 26(4):361-70. PubMed ID: 24827753
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy.
Bridgewood C; Sharif K; Sherlock J; Watad A; McGonagle D
Immunol Rev; 2020 Mar; 294(1):27-47. PubMed ID: 31957051
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
[TBL] [Abstract][Full Text] [Related]
12. Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
Rosine N; Miceli-Richard C
Front Immunol; 2020; 11():553742. PubMed ID: 33488572
[TBL] [Abstract][Full Text] [Related]
13. The IL-23/IL-17A axis in spondyloarthritis: therapeutics informing pathogenesis?
Siebert S; McGucken A; McInnes IB
Curr Opin Rheumatol; 2020 Jul; 32(4):349-356. PubMed ID: 32412997
[TBL] [Abstract][Full Text] [Related]
14. The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models.
Mandour M; Chen S; van de Sande MGH
Front Immunol; 2021; 12():618581. PubMed ID: 34267743
[TBL] [Abstract][Full Text] [Related]
15. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis.
Gravallese EM; Schett G
Nat Rev Rheumatol; 2018 Nov; 14(11):631-640. PubMed ID: 30266977
[TBL] [Abstract][Full Text] [Related]
16. Nature versus nurture in the spectrum of rheumatic diseases: Classification of spondyloarthritis as autoimmune or autoinflammatory.
Generali E; Bose T; Selmi C; Voncken JW; Damoiseaux JGMC
Autoimmun Rev; 2018 Sep; 17(9):935-941. PubMed ID: 30005857
[TBL] [Abstract][Full Text] [Related]
17. IL-23 and axial disease: do they come together?
Mease P; van den Bosch F
Rheumatology (Oxford); 2021 Oct; 60(Suppl 4):iv28-iv33. PubMed ID: 34668015
[TBL] [Abstract][Full Text] [Related]
18. IL-23/IL-17 axis in spondyloarthritis-bench to bedside.
Raychaudhuri SP; Raychaudhuri SK
Clin Rheumatol; 2016 Jun; 35(6):1437-41. PubMed ID: 27075462
[TBL] [Abstract][Full Text] [Related]
19. One year in review 2018: axial spondyloarthritis.
Carli L; Calabresi E; Governato G; Braun J
Clin Exp Rheumatol; 2019; 37(6):889-898. PubMed ID: 31796161
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory pathways in spondyloarthritis.
Hreggvidsdottir HS; Noordenbos T; Baeten DL
Mol Immunol; 2014 Jan; 57(1):28-37. PubMed ID: 23969080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]